These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7781140)
1. Safety and efficacy of intraperitoneal injection of etoposide in oil suspension in mice with peritoneal carcinomatosis. Lee JS; Takahashi T; Hagiwara A; Yoneyama C; Itoh M; Sasabe T; Muranishi S; Tashima S Cancer Chemother Pharmacol; 1995; 36(3):211-6. PubMed ID: 7781140 [TBL] [Abstract][Full Text] [Related]
2. [Toxic reduction and superior therapeutic effects on peritoneal carcinomatosis of etoposide particles suspended in oil in mice]. Lee M; Takahashi T; Hagiwara A; Iwamoto A; Shimotuma M; Yoneyama C; Itoh M; Sasabe T; Sakakura C; Shobayashi S Gan To Kagaku Ryoho; 1991 Aug; 18(11):2033-7. PubMed ID: 1652233 [TBL] [Abstract][Full Text] [Related]
3. Etoposide microcrystals suspended in oil: a new dosage form to peritoneal carcinomatosis in mice. Hagiwara A; Takahashi T; Sasabe T; Ito M; Lee M; Sakakura C; Shoubayashi S; Tashima S; Muranishi S Oncology; 1992; 49(3):233-6. PubMed ID: 1495752 [TBL] [Abstract][Full Text] [Related]
4. Selective delivery of etoposide to intraperitoneal tissues using a new dosage format: etoposide microcrystals suspended in oil. Hagiwara A; Takahashi T; Lee M; Sakakura C; Shoubayashi S; Tashima S; Yamamoto A; Muranishi S Anticancer Drugs; 1993 Feb; 4(1):27-31. PubMed ID: 8457710 [TBL] [Abstract][Full Text] [Related]
6. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289 [TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Apr; 414():1-284. PubMed ID: 12616284 [TBL] [Abstract][Full Text] [Related]
8. Tuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino mice. Khan A; Khan AA; Dwivedi V; Ahmad MG; Hakeem S; Owais M Mol Med; 2007; 13(5-6):266-76. PubMed ID: 17622310 [TBL] [Abstract][Full Text] [Related]
9. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic effects of cisplatin microspheres on peritoneal carcinomatosis in rodents. Hagiwara A; Takahashi T; Kojima O; Yamaguchi T; Sasabe T; Lee M; Sakakura C; Shoubayashi S; Ikada Y; Hyon SH Cancer; 1993 Feb; 71(3):844-50. PubMed ID: 8431867 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion. Patlolla RR; Vobalaboina V J Pharm Sci; 2005 Feb; 94(2):437-45. PubMed ID: 15614812 [TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287 [TBL] [Abstract][Full Text] [Related]
13. [Antitumor activity by long-term administration of low-dose etoposide]. Kusama K; Ekimoto H; Ishii T; Okamoto K; Takahashi K Gan To Kagaku Ryoho; 1991 May; 18(6):959-63. PubMed ID: 2029199 [TBL] [Abstract][Full Text] [Related]
14. Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma. Uchida N; Kasai H; Takeda Y; Maekawa R; Sugita K; Yoshioka T Anticancer Res; 1998; 18(1A):247-52. PubMed ID: 9568085 [TBL] [Abstract][Full Text] [Related]
15. Drug-targeting in combined cancer chemotherapy: tumor growth inhibition in mice by association of paclitaxel and etoposide with a cholesterol-rich nanoemulsion. Kretzer IF; Maria DA; Maranhão RC Cell Oncol (Dordr); 2012 Dec; 35(6):451-60. PubMed ID: 23055341 [TBL] [Abstract][Full Text] [Related]
16. A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin. Gunji S; Obama K; Matsui M; Tabata Y; Sakai Y Surgery; 2013 Nov; 154(5):991-9. PubMed ID: 24008088 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion. Reddy PR; Venkateswarlu V J Drug Target; 2005 Dec; 13(10):543-53. PubMed ID: 16390815 [TBL] [Abstract][Full Text] [Related]
18. Toxicology and Carcinogenesis Studies of Furan (CAS No. 110-00-9) in F344 Rats and B6C3F1 Mice(Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Jan; 402():1-286. PubMed ID: 12621516 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice. Shimada T; Nomura M; Yokogawa K; Endo Y; Sasaki T; Miyamoto K; Yonemura Y J Pharm Pharmacol; 2005 Feb; 57(2):177-81. PubMed ID: 15720780 [TBL] [Abstract][Full Text] [Related]
20. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors. Jiang H; Geng D; Liu H; Li Z; Cao J Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]